Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development
Authors:
- Ludovica CeciLCLudovica Ceci
- Tianhao ZhouTZTianhao Zhou
- Ilaria LenciILIlaria Lenci
- Vik MeadowsVMVik Meadows
- Lindsey KennedyLKLindsey Kennedy
- Ping LiPing Li
- Burcin EkserBEBurcin Ekser
- Martina MilanaMMMartina Milana
- Wenjun ZhangWZWenjun Zhang
- Chaodong WuCWChaodong Wu
- Keisaku SatoKSKeisaku Sato
- Sanjukta ChakrabortySanjukta Chakraborty
Open Access
Abstract
The poor prognosis of cholangiocarcinoma in humans is related to several factors, such as (i) the heterogeneity of the disease, (ii) the late onset of symptoms and (iii) the limited comprehension of the carcinogenic pathways determining neoplastic changes, which all limit the pursuit of appropriate treatment. Several risk factors have been recognized, including different infective, immune-mediated, and dysmorphogenic disorders of the biliary tree. In this review, we report the details of possible mechanisms that lead a specific premalignant pathological condition to become cholangiocarcinoma. For instance, during liver fluke infection, factors secreted from the worms may play a major role in pathogenesis. In primary sclerosing cholangitis, deregulation of histamine and bile-acid signaling may determine important changes in cellular pathways. The study of these molecular events may also shed some light on the pathogenesis of sporadic (unrelated to risk factors) forms of cholangiocarcinoma, which represent the majority (nearly 75%) of cases.Keywords
Funding Information
- Cancer Prevention and Research Institute of Texas ((CPRIT)-RP210213)
- theUnited States Department of Veteran’s Affairs, Biomedical Laboratory Research and Development Service from the United States Departmentof Veteran’s Affairs, Biomedical Laboratory Research and Development Service (1IK2BX005306, IK6BX005226, 1I01BX003031)
- National Institutes of Health (DK108959, DK119421, DK054811, DK115184, DK076898, DK107310, DK110035, DK062975, AA025997, AA025157)
- Hickam Endowed Chair, Gastroenterology, Medicine, Indiana University, the Indiana University Health – Indiana University School of Medicine Strategic Research Initiative (IK6BX004601, 5I01BX000574)
This publication has 108 references indexed in Scilit:
- From Cirrhosis to Hepatocellular Carcinoma: New Molecular Insights on Inflammation and Cellular SenescenceLiver Cancer, 2013
- Medical Risk Factors Associated with Cholangiocarcinoma in Taiwan: A Population-Based Case-Control StudyPLOS ONE, 2013
- Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and LaosActa Tropica, 2011
- Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinomaGut, 2011
- Polycystic Liver Diseases: Congenital Disorders of Cholangiocyte SignalingGastroenterology, 2011
- Risk factors for cholangiocarcinomaHepatology, 2011
- A Granulin-Like Growth Factor Secreted by the Carcinogenic Liver Fluke, Opisthorchis viverrini, Promotes Proliferation of Host CellsPLOS Pathogens, 2009
- Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infectionHepatology, 2008
- Biliary and Pancreatic Dysgenesis in Mice Harboring a Mutation in Pkhd1The American Journal of Pathology, 2008
- Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and WoundsPLOS Biology, 2004